"On 16th January, India takes a landmark step forward in fighting COVID-19. Starting that day, India’s nation-wide vaccination drive begins. Priority will be given to our brave doctors, healthcare workers, frontline workers including Safai Karamcharis," PM Modi tweeted soon after the announcement.
The announcement came after Prime Minister Narendra Modi chaired a high-level meeting to review status of Covid-19 pandemic in the country along with preparedness of the State/UTs for vaccination earlier today. Meeting was attended by Cabinet Secretary, Principal Secretary to PM, Health Secretary and other senior officials.
The Centre also said that a digital vaccine delivery management system will be implemented in order to give real-time info on vaccine stocks, storage temperature, tracking of beneficiaries. A digital platform will also be set up to help in automated session allocation, verification and post-vaccination certificate to recipients.
"After the detailed review, it was decided that in view of the forthcoming festivals including Lohri, Makar Sankranti, Pongal, Magh Bihu, etc, the COVID-19 vaccination will start from January 16, 2021," a government statement said.
ALSO READ | Covid-19 Vaccine Side Effects: Is There Legal Recourse For Recipients? Check Here
Announcing the rollout plan, the Centre also stated that 'Emergency Use Authorisation' or 'Accelerated Approval' has been granted by the National Regulator for two vaccines (Covishield and Covaxin) which have established safety and immunogenicity.
The decision comes a day after India successfully concluded second mock drill on COVID-19 vaccination on Friday in as many as 736 districts across 33 states and Union Territories.
Ahead of the Phase 1 vaccination drive, Prime Minister Narendra Modi will chair a meeting with the Chief Ministers of all the states on January 11 (Monday). The meeting is likely to be held at 4 pm.
In the meeting, PM is expected to discuss the detailed plans to roll Covid vaccines in all the states, following the Drug Controller General India's (DCGI) approval for the restricted emergency use of two vaccines Serum Institute's Covishield and Bharat Biotech's Covaxin.